Carmody, Thomas

Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

Ang, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., et al. (2022) · Psychological Medicine

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 12

A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes

Brown, E. S., Lu, H., Denniston, D., Uh, J., Thomas, B. P., Carmody, T. J., Auchus, R. J., Diaz-Arrastia, R., & Tamminga, C. (2013) · Journal of Affective Disorders

Stress Responses and CortisolMemory and Neural Mechanisms

Cited by 11

Toward a Definition of “No Meaningful Benefit” From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales

Zhang, C., Virani, S., Mayes, T., Carmody, T., Croarkin, P. E., Weinshilboum, R., Rush, A. J., Trivedi, M., Athreya, A. P., & Bobo, W. V. (2022) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 9

Comparison of Inflammatory Markers as Moderators of Depression Outcomes: A CO-MED Study

Czysz, A. H., Mason, B. L., Li, Q., Chin-Fatt, C., Minhajuddin, A., Carmody, T., & Trivedi, M. H. (2021) · Journal of Affective Disorders

Treatment of Major DepressionTryptophan and brain disorders

Cited by 4